GE Healthcare solution, billed as a 'unified approach to patient monitoring,' gains FDA clearance

GE Healthcare has received clearance from the U.S. Food and Drug Administration (FDA) for its patient monitoring platform, Carescape Canvas.

Carescape Canvas and Carescape One are part of an "adaptable ecosystem" that can scale up or scale down the monitoring of patients based on acuity. The platform is a FlexAcuity solution equipped with smart parameter technology for monitoring patients, leveraging micromodules that connect with standardized medical USB technology. Adding or disconnecting cables equipped for various configurations can enable more efficient care based on patient care needs, GE Healthcare said.

“As patient acuity and disease trends change rapidly, adaptability in the hospital setting is becoming more important,” Roland Schrewe, head of PICU at the University of Frankfurt, said in a statement. “We look for ways to improve the care experience by delivering quality clinical measurements where and when they are needed, giving care providers the information they need to make the best possible clinical decisions. GE Healthcare’s CARESCAPE Canvas provides a precise, standardized and flexible patient monitoring solution that adapts to patient needs with the ease of switching out a cable.”

According to GE, the company received 501(k) clearance for the platform from the FDA, which is known as premarket notification. The announcement comes just a few months after GE Healthcare became its own separate entity after GE spun off its businesses into three separate companies. 

The company also said the system is flexible and can be redeployed across a hospital enterprise with interchangeable frames for advanced parameters. The system is compatible with current devices available, but also with prior versions that are used across the 100M patients monitored by GE HealthCare devices.

“This new monitoring ecosystem has the potential for a hospital to have one single unified approach to patient monitoring that can be easily tailored for each patient,” said Neal Sandy, general manager of monitoring solutions for GE HealthCare. “GE HealthCare is committed to offering flexible solutions that enable care teams to focus on the patient, not the technology. CARESCAPE Canvas’ innovative approach, where software and patient parameters can change in a very nimble manner, enable a standardized ecosystem that can adapt to changing healthcare needs.”

Amy Baxter

Amy joined TriMed Media as a Senior Writer for HealthExec after covering home care for three years. When not writing about all things healthcare, she fulfills her lifelong dream of becoming a pirate by sailing in regattas and enjoying rum. Fun fact: she sailed 333 miles across Lake Michigan in the Chicago Yacht Club "Race to Mackinac."

Around the web

Compensation for heart specialists continues to climb. What does this say about cardiology as a whole? Could private equity's rising influence bring about change? We spoke to MedAxiom CEO Jerry Blackwell, MD, MBA, a veteran cardiologist himself, to learn more.

The American College of Cardiology has shared its perspective on new CMS payment policies, highlighting revenue concerns while providing key details for cardiologists and other cardiology professionals. 

As debate simmers over how best to regulate AI, experts continue to offer guidance on where to start, how to proceed and what to emphasize. A new resource models its recommendations on what its authors call the “SETO Loop.”